Aclaris Therapeutics, Inc. (ACRS) Social Stream



Aclaris Therapeutics, Inc. (ACRS): $8.33

0.08 (+0.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ACLARIS THERAPEUTICS INC (ACRS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ACLARIS THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-05-20 4 $50 $26 $34 $8.24 312.62%
2022-08-01 5 $50 $26 $34.8 $8.24 322.33%
2022-08-08 6 $50 $26 $34.8 $8.24 322.33%
2022-10-06 6 $50 $26 $34.333 $8.24 316.66%
2022-11-09 7 $50 $26 $34.333 $8.24 316.66%
2022-12-01 8 $50 $25 $33 $8.24 300.49%
2023-02-24 9 $50 $25 $32.5 $8.24 294.42%
2023-03-01 9 $50 $25 $33.5 $8.24 306.55%
2023-03-07 9 $43 $11 $30 $8.24 264.08%
2023-03-09 9 $43 $11 $29.125 $8.24 253.46%

The Trend in the Analyst Price Target


ACRS's average price target has moved up $2.45 over the prior 24 months.

ACRS reports an average of 163.96% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-11 6 50 26 34.800 10.16 242.52%
2022-05-20 5 50 26 34.000 12.11 180.76%
2022-10-06 6 50 26 34.333 16.70 105.59%
2022-11-08 7 50 26 34.333 16.21 111.8%
2023-02-24 9 50 25 32.500 12.07 169.26%

ACRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 9 0 0 0 0 9

The Trend in the Broker Recommendations


Over the past 120 days, ACRS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, ACLARIS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1147.24% of them.
  • ACLARIS THERAPEUTICS INC's variance in analysts' estimates is lower than -922.24% of all US stocks.
  • In terms of how ACLARIS THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1059.47% of that group.
  • In the context of stocks in the small market cap category, ACLARIS THERAPEUTICS INC's average analyst price target is greater than 999.88% of them.

In the Pharmaceutical Products industry, WVE, PDSB, and EPIX are the three stocks most similar to ACLARIS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ACRS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7428 seconds.